Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 901

1.

Agreement between Framingham Risk Score and United Kingdom Prospective Diabetes Study Risk Engine in Identifying High Coronary Heart Disease Risk in North Indian Population.

Bansal D, Nayakallu RS, Gudala K, Vyamasuni R, Bhansali A.

Diabetes Metab J. 2015 Aug;39(4):321-7. doi: 10.4093/dmj.2015.39.4.321. Epub 2015 Jul 8.

2.

Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial.

Bittner V, Bertolet M, Barraza Felix R, Farkouh ME, Goldberg S, Ramanathan KB, Redmon JB, Sperling L, Rutter MK; BARI 2D Study Group.

J Am Coll Cardiol. 2015 Aug 18;66(7):765-73. doi: 10.1016/j.jacc.2015.06.019.

PMID:
26271057
3.

Age- and Gender-Related Differences in LDL-Cholesterol Management in Outpatients with Type 2 Diabetes Mellitus.

Russo G, Pintaudi B, Giorda C, Lucisano G, Nicolucci A, Cristofaro MR, Suraci C, Mulas MF, Napoli A, Rossi MC, Manicardi V.

Int J Endocrinol. 2015;2015:957105. doi: 10.1155/2015/957105. Epub 2015 Mar 19.

4.

Risk score model for the assessment of coronary artery disease in asymptomatic patients with type 2 diabetes.

Park GM, An H, Lee SW, Cho YR, Gil EH, Her SH, Kim YH, Lee CW, Koh EH, Lee WJ, Kim MS, Lee KU, Kang JW, Lim TH, Park SW, Park SJ, Park JY.

Medicine (Baltimore). 2015 Jan;94(4):e508. doi: 10.1097/MD.0000000000000508.

PMID:
25634204
5.

Novel KIF6 polymorphism increases susceptibility to type 2 diabetes mellitus and coronary heart disease in Han Chinese men.

Wu G, Li GB, Dai B, Zhang DQ.

J Diabetes Res. 2014;2014:871439. doi: 10.1155/2014/871439. Epub 2014 Dec 31.

6.

Investigation of the monocyte diapedesis-related LFA-1 and JAM-A gene variants in Turkish coronary heart disease patients.

Tokat B, Kurt O, Bugra Z, Ozturk O, Yilmaz-Aydogan H.

Meta Gene. 2013 Nov 22;2:1-10. doi: 10.1016/j.mgene.2013.10.010. eCollection 2014 Dec.

7.

The association of common polymorphisms in miR-196a2 with waist to hip ratio and miR-1908 with serum lipid and glucose.

Ghanbari M, Sedaghat S, de Looper HW, Hofman A, Erkeland SJ, Franco OH, Dehghan A.

Obesity (Silver Spring). 2015 Feb;23(2):495-503. doi: 10.1002/oby.20975. Epub 2014 Dec 31.

PMID:
25557604
8.

Hepatic lipase (LIPC) C-514T gene polymorphism is associated with cardiometabolic parameters and cardiovascular risk factors but not with fatty liver in Mexican population.

Posadas-Sánchez R, Ocampo-Arcos WA, López-Uribe ÁR, Posadas-Romero C, Villarreal-Molina T, León EÁ, Pérez-Hernández N, Rodríguez-Pérez JM, Cardoso-Saldaña G, Medina-Urrutia A, Vargas-Alarcón G.

Exp Mol Pathol. 2015 Feb;98(1):93-8. doi: 10.1016/j.yexmp.2014.12.010. Epub 2014 Dec 27.

PMID:
25550127
10.

Type 2 diabetes is associated with a worse functional outcome of ischemic stroke.

Tziomalos K, Spanou M, Bouziana SD, Papadopoulou M, Giampatzis V, Kostaki S, Dourliou V, Tsopozidi M, Savopoulos C, Hatzitolios AI.

World J Diabetes. 2014 Dec 15;5(6):939-44. doi: 10.4239/wjd.v5.i6.939.

11.

Genetic basis of dyslipidemia in disease precipitation of coronary artery disease (CAD) associated type 2 diabetes mellitus (T2DM).

Raj R, Bhatti JS, Badada SK, Ramteke PW.

Diabetes Metab Res Rev. 2014 Dec 3. doi: 10.1002/dmrr.2630. [Epub ahead of print]

PMID:
25470794
12.

Non-HDL cholesterol is a better target for predicting periprocedural myocardial injury following percutaneous coronary intervention in type 2 diabetes.

Zeng RX, Li XL, Zhang MZ, Guo YL, Zhu CG, Guo LH, Li S, Zhang Y, Li JJ.

Atherosclerosis. 2014 Dec;237(2):536-43. doi: 10.1016/j.atherosclerosis.2014.10.030. Epub 2014 Oct 22.

PMID:
25463086
13.

A new coronary artery disease grading system correlates with numerous routine parameters that were associated with atherosclerosis: a grading system for coronary artery disease severity.

Sponder M, Fritzer-Szekeres M, Marculescu R, Litschauer B, Strametz-Juranek J.

Vasc Health Risk Manag. 2014 Nov 7;10:641-7. doi: 10.2147/VHRM.S68919. eCollection 2014.

14.

Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.

Muhlestein JB, Lappé DL, Lima JA, Rosen BD, May HT, Knight S, Bluemke DA, Towner SR, Le V, Bair TL, Vavere AL, Anderson JL.

JAMA. 2014 Dec 3;312(21):2234-43. doi: 10.1001/jama.2014.15825.

PMID:
25402757
15.

Prevalence of stroke and metabolic disorders in the middle-aged and elderly Chinese with type 2 diabetes.

Zhang X, Mu Y, Yan W, Ba J, Li H.

Chin Med J (Engl). 2014;127(20):3537-42.

PMID:
25316225
16.

Prevalence of dyslipidemia in adult Indian diabetic patients: A cross sectional study (SOLID).

Mithal A, Majhi D, Shunmugavelu M, Talwarkar PG, Vasnawala H, Raza AS.

Indian J Endocrinol Metab. 2014 Sep;18(5):642-7. doi: 10.4103/2230-8210.139220.

17.

Vitamin B12 deficiency is associated with adverse lipid profile in Europeans and Indians with type 2 diabetes.

Adaikalakoteswari A, Jayashri R, Sukumar N, Venkataraman H, Pradeepa R, Gokulakrishnan K, Anjana RM, McTernan PG, Tripathi G, Patel V, Kumar S, Mohan V, Saravanan P.

Cardiovasc Diabetol. 2014 Sep 26;13:129. doi: 10.1186/s12933-014-0129-4.

18.

N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.

Price AH, Welsh P, Weir CJ, Feinkohl I, Robertson CM, Morling JR, McLachlan S, Strachan MW, Sattar N, Price JF.

Diabetologia. 2014 Dec;57(12):2505-12. doi: 10.1007/s00125-014-3375-9. Epub 2014 Sep 18.

PMID:
25231020
19.

Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: the Basque Country Prospective Complications and Mortality Study risk engine (BASCORE).

Piniés JA, González-Carril F, Arteagoitia JM, Irigoien I, Altzibar JM, Rodriguez-Murua JL, Echevarriarteun L; Sentinel Practice Network of the Basque Country.

Diabetologia. 2014 Nov;57(11):2324-33. doi: 10.1007/s00125-014-3370-1. Epub 2014 Sep 12.

PMID:
25212259
20.

Coronary artery calcification in obese youth: what are the phenotypic and metabolic determinants?

Bacha F, Edmundowicz D, Sutton-Tyrell K, Lee S, Tfayli H, Arslanian SA.

Diabetes Care. 2014 Sep;37(9):2632-9. doi: 10.2337/dc14-0193.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk